Drug General Information (ID: DDIN1R2GZQ)
Drug Name			Dofetilide		Drug Info		Ivosidenib		Drug Info
Drug Type		Small molecule				Small molecule
Therapeutic Class		Antiarrhythmic Agents				Antineoplastics
Structure

Mechanism of Dofetilide-Ivosidenib Interaction (Severity Level: Major)
Increased risk of prolong QT interval Click to Show/Hide Mechanism Graph
Drug Name		Dofetilide				Ivosidenib
Mechanism		Prolong QT interval				Prolong QT interval
Key Mechanism Factor 1
		Factor Name		QT interval
		Factor Description		Long QT syndrome is a heart signaling disorder that can cause a fast, chaotic heartbeat (arrhythmia). Many people may not exhibit symptoms, and usually the condition is detected during routine medical tests. In others, the most common symptoms include: sudden fainting, palpitations, dizziness, seizures, sudden death.
Mechanism Description		Increased risk of prolong QT interval by the combination of Dofetilide and Ivosidenib

Recommended Action
Management		Coadministration of dofetilide with other drugs that can prolong the QT interval has not been studied and is not recommended.

References
1	Canadian Pharmacists Association.
2	Cerner Multum, Inc. "Australian Product Information.".
3	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
4	Product Information. Tikosyn (dofetilide) Pfizer US Pharmaceuticals, Atlanta, GA.